We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWL:ASXNetwealth Group Ltd. Analysis

Data as of 2026-03-15 - not real-time

A$21.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Netwealth (NWL) is trading at AUD 21.5, well below its 20‑day (24.29) and 50‑day (24.55) SMAs and far under the DCF‑derived fair value of AUD 28.21, implying a potential upside of roughly 30%. Fundamentally the company delivered 23.8% revenue growth, gross margins of 66% and operating margins near 49%, while generating AUD 141 m of operating cash flow and a free cash flow of AUD 189 m, underscoring a robust earnings engine. However, the stock shows a bearish technical picture – MACD is negative, RSI sits at 35 (approaching oversold), and volume is decreasing, with a 30‑day volatility of 69% and beta of 1.25, indicating heightened price swings. Recent half‑year earnings highlighted record inflows, with funds under administration rising 23.6% to AUD 125.6 bn and net new flows of AUD 8.2 bn, reinforcing the growth narrative but the dividend payout ratio of 166% flags sustainability concerns.
Analyst consensus remains a “Buy” with a median target of AUD 28.63, suggesting the market still sees upside, yet the current PE of 93× versus an industry average of 34× and a price‑to‑book of 35× point to a premium valuation. Investors must weigh the strong cash generation and growth against the elevated volatility, bearish short‑term momentum, and an unsustainable dividend policy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and RSI near oversold levels
  • Price at immediate support around AUD 21.08
  • High short‑term volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Record inflows and expanding funds under administration
  • DCF fair value indicating ~30% upside and analyst target around AUD 28.5

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable high ROE and ROA indicating competitive advantage
  • Continued platform adoption and potential for further fee‑based revenue
  • Valuation premium offset by growth trajectory, though dividend policy remains a risk

Key Metrics & Analysis

Financial Health

Revenue Growth23.80%
Profit Margin15.71%
P/E Ratio93.5
ROE34.57%
ROA41.82%
Debt/Equity8.37
P/B Ratio35.2
Op. Cash FlowA$141.3M
Free Cash FlowA$189.4M
Industry P/E33.7

Technical Analysis

TrendBearish
RSI35.6
SupportA$21.08
ResistanceA$27.43
MA 20A$24.29
MA 50A$24.55
MA 200A$29.96
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$28.21
Target PriceA$28.14
Upside/Downside30.89%
GradeUndervalued
TypeGrowth
Dividend Yield1.95%

Risk Assessment

Beta1.25
Volatility69.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.